Skip to main content
. 2023 Dec 6;15:1282962. doi: 10.3389/fnagi.2023.1282962

Table 1.

Demographic and clinical characteristics of PD-EDS and PD-noEDS group.

PD-EDS (n = 16) PD-noEDS (n = 41) p-value
Age 70.75 (58.93, 74.75) 62.00 (53.50, 70.60) 0.079a
Gender (M/F) 13/3 23/18 0.077b
Onset age (y) 68.45 (54.43, 72.45) 61.10 (51.70, 68.55) 0.077a
Disease duration (y) 2.45 (1.58, 3.83) 1.80 (1.10, 3.10) 0.324a
Education (y) 17.4 (14.5, 20.0) 18.0 (16.0, 20.0) 0.851a
H-Y staging 2 (1, 2) 2 (1, 2) 0.884a
UPDRS-III 24.50 (16.25, 32.50) 19.00 (14.00, 32.00) 0.374a
MoCA 26.5 (26.0, 29.0) 27.0 (25.5, 29.0) 0.815a
STAI-S 48.00 (44.25, 49.75) 47.00 (43.50, 50.00) 0.865a
STAI-T 45.94 ± 1.17 45.88 ± 0.56 0.957c
GDS 2.50 (1.00, 3.75) 1.00 (0, 2.50) 0.069a
RBDSQ 2.0 (1.0, 4.5) 3.0 (2.0, 4.5) 0.109a
ESS 12.00 (11.00,12.75) 2.00 (2.00, 3.00) < 0.001a

Parametric variables are presented as mean ± SD, and non-parametric variables are presented as median (interquartile range). PD-EDS, Parkinson’s disease with excessive daytime sleepiness; PD-noEDS, Parkinson’s disease without excessive daytime sleepiness; M, Male; F, Female; y, Year; H-Y, Hoehn and Yahr scale; UDPRS-III, part III of the Unified Parkinson’s Disease Rating Scale; MoCA, Montreal Cognitive Assessment; STAI-S, state–trait anxiety inventory-state score; STAI-T, state–trait anxiety inventory-trait score; GDS, geriatric depression scale, RBDSQ, rapid eye movement sleep behavior disorder questionnaire; ESS, Epworth Sleepiness Scale. *p < 0.05.

a

Mann–Whitney U test.

b

Chi-squared test.

c

Two-sample t-test.